中东和非洲膀胱过度活动症治疗市场预测至 2028 年 – COVID-19 影响和区域分析 – 按药物治疗（抗胆碱能药物、米拉贝隆、肉毒杆菌、神经刺激和膀胱灌注）和疾病类型（特发性膀胱过度活动症和神经源性膀胱） � �
No. of Pages: 134 | Report Code: BMIRE00027936 | Category: Life Sciences
No. of Pages: 134 | Report Code: BMIRE00027936 | Category: Life Sciences
合并数量不断增加和收购以推动中东和中东地区的发展未来几年非洲膀胱过度活跃治疗市场
通过并购 (M&A)，公司可以通过进入非洲市场来获得竞争优势。并获取新技术。膀胱过度活动症治疗市场正在进行的并购正在为各公司创造增长机会。 2021 年 7 月，Uro Medical 通过收购 Micron Medical 加强了其泌尿科产品组合，该公司提供无线供电、可注射、微技术神经刺激器，专注于治疗膀胱过度活动症。这些神经刺激器可以很容易地融入患者体内。为日常生活提供便捷、安全、微创、经济的泌尿外科治疗选择。 2021 年 2 月，医疗技术公司 Axonics Modulation Technologies, Inc. 收购了 Contura Ltd. 及其专有产品 Bulkamid，这是一种针对女性压力性尿失禁 (SUI) 的尿道填充剂。 Axonics 生产和销售用于治疗泌尿和肠道功能障碍的新型植入式骶神经调节 (SNM) 装置。收购 Contura Ltd. 提供了在全球范围内扩展 SNM 业务并服务于渗透率极低的大型 SUI 市场的机会。该公司计划为泌尿妇科医生和泌尿科医生提供一整套临床差异化的失禁解决方案来治疗他们的患者。因此，越来越多的并购正在推动中东和中东地区的发展。非洲膀胱过度活动症治疗市场增长。
中东和非洲非洲膀胱过度活动症治疗市场概览
中东和非洲非洲膀胱过度活动症治疗市场分为阿联酋、沙特阿拉伯、南非以及中东和非洲其他地区。非洲。市场增长归因于慢性病患病率的增加以及整个地区医学研究的不断增长。尿失禁是一种临床病症，在沙特阿拉伯女性中更为常见。根据国家医学图书馆发表的《Cureus 医学科学杂志》，2022 年，沙特阿拉伯吉达和利雅得的尿失禁患病率估计分别为 41.4% 和 29%。年龄、肥胖、合并症、子宫切除术和多产等一些因素会导致尿失禁的发生。此外，多胎妊娠病例和老年人口的增加也是导致膀胱过度活动症治疗市场增长的几个因素。此外，慢性病患病率的上升以及对快速诊断、有效治疗方案和预防措施的高需求正在推动沙特阿拉伯的市场增长。沙特阿拉伯卫生部通过 2,259 个中心向约 13,455 人提供初级卫生服务。初级保健中心是第一个处理泌尿科相关问题等新出现的投诉的机构。它有助于评估初级卫生中心医生观察到的常见泌尿科问题的知识和实践模式。因此，预计上述因素将在未来几年推动膀胱过度活动症治疗市场的增长。
中东和中东地区非洲膀胱过度活动症治疗市场细分
中东和非洲非洲膀胱过度活动症治疗市场根据药物治疗、疾病类型和国家进行细分。
基于药物疗法，中东和非洲非洲膀胱过度活动症治疗市场分为抗胆碱能药物、米拉贝隆、肉毒杆菌、神经刺激和膀胱灌注。米拉贝隆细分市场在 2022 年占据最大市场份额。
根据疾病类型，中东和非洲地区的市场份额最高。非洲膀胱过度活动症治疗市场分为特发性膀胱过度活动症和神经源性膀胱。 2022 年，特发性膀胱过度活动症细分市场占据了更大的市场份额。
基于国家、中东和非洲地区。非洲膀胱过度活动症治疗市场分为沙特阿拉伯、南非、阿联酋以及中东和非洲其他地区。非洲。沙特阿拉伯将在 2022 年占据市场主导地位。
AbbVie Inc; Alembic 制药有限公司；安斯泰来制药公司；远藤制药公司；久光制药有限公司；美敦力公司；辉瑞公司；和 Teva Pharmaceutical Industries Ltd 是在中东和非洲地区运营的领先公司。非洲膀胱过度活动症治疗市场。
Strategic insights for Middle East & Africa Overactive Bladder Treatment involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 290.94 Million |
| Market Size by 2028 | US$ 330.17 Million |
| Global CAGR (2022 - 2028) | 2.1% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By 药物治疗
|
| Regions and Countries Covered | 中东和非洲
|
| Market leaders and key company profiles |
The regional scope of Middle East & Africa Overactive Bladder Treatment refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Middle East & Africa Overactive Bladder Treatment Market is valued at US$ 290.94 Million in 2022, it is projected to reach US$ 330.17 Million by 2028.
As per our report Middle East & Africa Overactive Bladder Treatment Market, the market size is valued at US$ 290.94 Million in 2022, projecting it to reach US$ 330.17 Million by 2028. This translates to a CAGR of approximately 2.1% during the forecast period.
The Middle East & Africa Overactive Bladder Treatment Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Overactive Bladder Treatment Market report:
The Middle East & Africa Overactive Bladder Treatment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East & Africa Overactive Bladder Treatment Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East & Africa Overactive Bladder Treatment Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Middle East & Africa Overactive Bladder Treatment Market
